Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
11
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Bisker-Leib Vered | Director | 6 | $0 | $0 | 2023-01-19 |
| Gordon Gary B. | Chief Medical Officer | 14 | $0 | $97.5K | 2023-01-19 |
| aMoon Growth Fund Limited Partnership | 10% Owner | 6 | $12.00M | $0 | 2023-01-19 |
| Mamluk Roni | President & CEO | 15 | $0 | $931.0K | 2023-01-19 |
| Spiegel Robert J. | Director | 6 | $0 | $0 | 2023-01-19 |
| Maimon Yossi | CFO, Secretary and Treasurer | 10 | $0 | $0 | 2023-01-19 |
| SIDRANSKY DAVID | Director | 13 | $3.7K | $0 | 2023-01-19 |
| GOLDBERG MURRAY A | Director | 6 | $0 | $0 | 2023-01-19 |
| Sone Todd | Director | 1 | $0 | $0 | 2021-06-10 |
| Israel Biotech Fund I, L.P. | 10% Owner | 5 | $3.38M | $0 | 2020-05-12 |
| Harel Insurance Investments & Financial Services Ltd. | 10% Owner | 6 | $8.25M | $0 | 2020-05-12 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Mamluk Roni | President & CEO | D To issuer deriv | 2023-01-19 | 2023-01-23 | 127,800 | — | $0 | 0 | SEC↗ |
| Mamluk Roni | President & CEO | D To issuer deriv | 2023-01-19 | 2023-01-23 | 76,680 | — | $0 | 0 | SEC↗ |
| Mamluk Roni | President & CEO | D To issuer deriv | 2023-01-19 | 2023-01-23 | 47,299 | — | $0 | 0 | SEC↗ |
| Bisker-Leib Vered | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 8,750 | — | $0 | 0 | SEC↗ |
| Bisker-Leib Vered | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| Bisker-Leib Vered | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| GOLDBERG MURRAY A | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 17,500 | — | $0 | 0 | SEC↗ |
| GOLDBERG MURRAY A | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| GOLDBERG MURRAY A | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| GOLDBERG MURRAY A | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| Spiegel Robert J. | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| Spiegel Robert J. | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 17,500 | — | $0 | 0 | SEC↗ |
| Spiegel Robert J. | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 6,250 | — | $0 | 0 | SEC↗ |
| Spiegel Robert J. | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| SIDRANSKY DAVID | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| SIDRANSKY DAVID | Director | D To issuer deriv | 2023-01-19 | 2023-01-23 | 12,500 | — | $0 | 0 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 19,170 | — | $0 | 0 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 31,950 | — | $0 | 0 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 89,000 | — | $0 | 0 | SEC↗ |
| Maimon Yossi | CFO, Secretary and Treasurer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 31,950 | — | $0 | 0 | SEC↗ |
| Maimon Yossi | CFO, Secretary and Treasurer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 19,170 | — | $0 | 0 | SEC↗ |
| Maimon Yossi | CFO, Secretary and Treasurer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 9,460 | — | $0 | 0 | SEC↗ |
| Maimon Yossi | CFO, Secretary and Treasurer | D To issuer deriv | 2023-01-19 | 2023-01-23 | 70,500 | — | $0 | 0 | SEC↗ |
| Mamluk Roni | President & CEO | D To issuer | 2023-01-19 | 2023-01-23 | 265,345 | — | $0 | 0 | SEC↗ |
| SIDRANSKY DAVID | Director | D To issuer | 2023-01-19 | 2023-01-23 | 250 | — | $0 | 0 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | D To issuer | 2023-01-19 | 2023-01-23 | 58,520 | — | $0 | 0 | SEC↗ |
| Maimon Yossi | CFO, Secretary and Treasurer | D To issuer | 2023-01-19 | 2023-01-23 | 69,872 | — | $0 | 0 | SEC↗ |
| aMoon Growth Fund Limited Part | 10% Owner | D To issuer | 2023-01-19 | 2023-01-24 | 2,991,473 | — | $0 | 0 | SEC↗ |
| Bisker-Leib Vered | Director | A Award deriv | 2022-06-13 | 2022-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Spiegel Robert J. | Director | A Award deriv | 2022-06-13 | 2022-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| SIDRANSKY DAVID | Director | A Award deriv | 2022-06-13 | 2022-06-15 | 12,500 | — | $0 | 12,500 | SEC↗ |
| GOLDBERG MURRAY A | Director | A Award deriv | 2022-06-13 | 2022-06-15 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Mamluk Roni | President & CEO | A Award | 2022-05-16 | 2022-05-16 | 120,000 | — | $0 | 265,345 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | A Award | 2022-05-16 | 2022-05-16 | 50,000 | — | $0 | 58,520 | SEC↗ |
| Maimon Yossi | CFO, Secretary & Treasurer | A Award | 2022-05-16 | 2022-05-16 | 50,000 | — | $0 | 69,872 | SEC↗ |
| Mamluk Roni | President & CEO | A Award deriv | 2022-01-03 | 2022-01-05 | 127,800 | — | $0 | 127,800 | SEC↗ |
| Maimon Yossi | CFO, Secretary & Treasurer | A Award deriv | 2022-01-03 | 2022-01-05 | 31,950 | — | $0 | 31,950 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | A Award deriv | 2022-01-03 | 2022-01-05 | 31,950 | — | $0 | 31,950 | SEC↗ |
| Sone Todd | Director | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| GOLDBERG MURRAY A | Director | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| SIDRANSKY DAVID | Director | A Award deriv | 2021-06-10 | 2021-06-14 | 12,500 | — | $0 | 12,500 | SEC↗ |
| Spiegel Robert J. | Director | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Bisker-Leib Vered | Director | A Award deriv | 2021-06-10 | 2021-06-14 | 6,250 | — | $0 | 6,250 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | M Exercise deriv | 2021-02-24 | 2021-02-26 | 3,000 | — | $0 | 89,000 | SEC↗ |
| Mamluk Roni | President & CEO | S Sale | 2021-02-24 | 2021-02-24 | 10,800 | $17.40 | $187.9K | 145,345 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | M Exercise | 2021-02-24 | 2021-02-26 | 3,000 | $5.16 | $15.5K | 11,520 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | S Sale | 2021-02-24 | 2021-02-26 | 3,000 | $17.46 | $52.4K | 8,520 | SEC↗ |
| Mamluk Roni | President & CEO | S Sale | 2021-02-23 | 2021-02-24 | 7,126 | $17.89 | $127.5K | 156,145 | SEC↗ |
| Mamluk Roni | President & CEO | S Sale | 2021-02-22 | 2021-02-24 | 15,200 | $19.86 | $301.9K | 163,271 | SEC↗ |
| Mamluk Roni | President & CEO | S Sale | 2021-01-21 | 2021-01-22 | 1,406 | $15.04 | $21.1K | 178,471 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | M Exercise deriv | 2021-01-20 | 2021-01-22 | 3,000 | — | $0 | 92,000 | SEC↗ |
| Mamluk Roni | President & CEO | S Sale | 2021-01-20 | 2021-01-22 | 19,466 | $15.03 | $292.6K | 179,877 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | M Exercise | 2021-01-20 | 2021-01-22 | 3,000 | $5.16 | $15.5K | 11,520 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | S Sale | 2021-01-20 | 2021-01-22 | 3,000 | $15.03 | $45.1K | 8,520 | SEC↗ |
| Mamluk Roni | President & CEO | A Award deriv | 2021-01-04 | 2021-01-06 | 76,680 | — | $0 | 76,680 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | A Award deriv | 2021-01-04 | 2021-01-06 | 19,170 | — | $0 | 19,170 | SEC↗ |
| Maimon Yossi | CFO, Secretary & Treasurer | A Award deriv | 2021-01-04 | 2021-01-06 | 19,170 | — | $0 | 19,170 | SEC↗ |
| Mamluk Roni | President & CEO | A Award | 2021-01-04 | 2021-01-06 | 34,080 | — | $0 | 199,343 | SEC↗ |
| Gordon Gary B. | Chief Medical Officer | A Award | 2021-01-04 | 2021-01-06 | 8,520 | — | $0 | 8,520 | SEC↗ |
| Maimon Yossi | CFO, Secretary & Treasurer | A Award | 2021-01-04 | 2021-01-06 | 8,520 | — | $0 | 19,872 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-12-23 | 2021-03-08 | 4 | $11.56 | $46 | 250 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-09-14 | 2021-03-08 | 1 | $10.70 | $11 | 246 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-09-11 | 2021-03-08 | 10 | $10.07 | $101 | 245 | SEC↗ |
| Bisker-Leib Vered | Director | A Award deriv | 2020-08-18 | 2020-08-20 | 8,750 | — | $0 | 8,750 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-08-14 | 2021-03-08 | 5 | $11.07 | $55 | 235 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-07-17 | 2021-03-08 | 4 | $11.86 | $47 | 230 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-07-07 | 2021-03-08 | 1 | $9.60 | $10 | 226 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-05-12 | 2021-03-08 | 25 | $15.02 | $376 | 225 | SEC↗ |
| aMoon 2 Fund Limited Partnersh | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 738,462 | — | $0 | 0 | SEC↗ |
| aMoon 2 Fund Limited Partnersh | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 1,017,848 | — | $0 | 0 | SEC↗ |
| Israel Biotech Fund I, L.P. | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 738,462 | — | $0 | 0 | SEC↗ |
| Israel Biotech Fund I, L.P. | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 423,514 | — | $0 | 0 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 307,692 | — | $0 | 0 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | C Conversion deriv | 2020-05-12 | 2020-05-14 | 211,757 | — | $0 | 0 | SEC↗ |
| aMoon 2 Fund Limited Partnersh | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 369,231 | — | $0 | 1,682,549 | SEC↗ |
| aMoon 2 Fund Limited Partnersh | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 508,924 | — | $0 | 2,191,473 | SEC↗ |
| aMoon 2 Fund Limited Partnersh | 10% Owner | P Buy | 2020-05-12 | 2020-05-14 | 800,000 | $15.00 | $12.00M | 2,991,473 | SEC↗ |
| Israel Biotech Fund I, L.P. | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 211,757 | — | $0 | 3,090,119 | SEC↗ |
| Israel Biotech Fund I, L.P. | 10% Owner | P Buy | 2020-05-12 | 2020-05-14 | 225,000 | $15.00 | $3.38M | 3,315,119 | SEC↗ |
| Israel Biotech Fund I, L.P. | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 369,231 | — | $0 | 2,878,362 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 307,692 | — | $0 | 1,402,077 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | P Buy | 2020-05-12 | 2020-05-14 | 50,000 | $15.00 | $750.0K | 1,663,834 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | C Conversion | 2020-05-12 | 2020-05-14 | 211,757 | — | $0 | 1,613,834 | SEC↗ |
| Harel Insurance Investments & | 10% Owner | P Buy | 2020-05-12 | 2020-05-14 | 500,000 | $15.00 | $7.50M | 2,163,834 | SEC↗ |
| SIDRANSKY DAVID | Director | P Buy | 2020-05-08 | 2021-03-08 | 200 | $15.27 | $3.1K | 200 | SEC↗ |
| Mamluk Roni | President & CEO | A Award deriv | 2020-05-07 | 2020-05-11 | 47,299 | — | $0 | 47,299 | SEC↗ |
| Mamluk Roni | President & CEO | A Award | 2020-05-07 | 2020-05-11 | 47,299 | — | $0 | 165,263 | SEC↗ |
| Maimon Yossi | CFO, Secretary & Treasurer | A Award | 2020-05-07 | 2020-05-11 | 11,352 | — | $0 | 11,352 | SEC↗ |